Investing.com UK - Financial Markets Worldwide
Get 40% Off
Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Cambridge Nutritional Sciences PLC (CNSL)

London
Currency in GBP
Disclaimer
3.85
-0.15(-3.75%)
Closed

CNSL Price Commentary

£4m incoming, focus back on food intolerance business and targeting break even EBITDA by year end 👍🏻
A good recovery play. This traded around 8-10p before the Covid and gov contract madness.
Glad I got stopped out at 95p
what a hero you are
Here is a tip for you… look at the price of most pharma stocks before covid and thats whete they ate ahain now, or atlesdt heading that way. Full stop
yes pretty disappointing for investors! & revenues are pretty much the same as it was despite 2 years of massive tailwinds!!!
We definatly are not back🙈
Finally we back
6 months too late.
Let's see if we get some orders
lifestyle company completely incapable of growth. Competence level of middle managers (or lower) running a listed company.
The directors will soon be looking towards guarding their pay cheques so If they are going to raise money this current financia climate is not the best so the money vultures will be circlng for a heavy discount,larger than most expect with alllied dilution.Even then it will be difficult to look forward in business until the NHS mstter is fully dealt with.
Amateurs. Utterly shambolic management.
Here's to a new start, up and onwards.
What makes you so certain?
Good joke
Definitely a good joke after todays decline. LOK
Omega have taken “The Government” to court for failure to fulfill their contract for Omega to supply LFT’s. Then “The Government” demanding £2.5m repayment for the funds injected for equipment etc for the production of LFT’s 🤔
no they haven't
Clearly you did not read this, apologies that I stated going to court, but the rest is correct:Shares in Omega Diagnostics lost more than a quarter of their value yesterday after the company was hit with a £2.5 million bill for equipment to produce Covid tests that the UK Government no longer wants.The money was provided to Omega as a pre-production payment to ramp up capacity to make hundreds of millions of lateral flow antigen tests for the Department of Health and Social Care (DHSC). However, Omega confirmed last month that the contract has expired and will not proceed into Phase 2.The DHSC has now asked Omega to submit a proposal for returning the £2.5m pre-production payment made last year to purchase equipment for high-volume manufacturing at its headquarters in Alva.Having taken initial legal advice, Omega said it does not believe it is required to repay the money. It added that the board will continue to take further legal advice and hopes to reach a resolution “swiftly”
It is clearly disappointing to receive this request for repayment given the efforts we have gone to ensure manufacturing capacity for Covid-19 lateral flow test was available for the DHSC and that we did not progress to Phase 2 of the contract due to the lack of confirmation from the DHSC regarding which test they require us to manufacture,” chief executive Colin King said.Acting in good faith we used these pre-production payments, along with our own funds, to upgrade our manufacturing facilities to be able to integrate the Government-furnished equipment and bringing on the additional staff required to be able to supply the DHSC using our UK-based volume manufacturing services. We therefore are confident that, having sought legal advice, we will not be required to make this repayment.”Announced in March 2020, the DHSC agreement could have been worth up to £374m.
Martian invasion
what news has brought this increase on?
Mologic about to release CE aquisition
We all feel each others pain
Government failure to fullfill the “banded contract”, slow progress for continued development and results are all contributing factors…stop losses are not an option, hold our nerves and hope all comes good?
Joke
lied to continually
Freefall🙄
This news is like waiting for lord lucan to turn up🤷🏼‍♂️
Definitely
I’m convinced we will see this along with other pharmaceutical companies developing LFT’s / medications for COVID and other lung related conditions, rocket. We are coming into the winter when these conditions will only worsen, though i hope without tragedy, and these tests and medications will help those affected. HOLD
Come on we are now ready and perfectly positioned in the coming weeks
Ffs come on omega
https://www.business-live.co.uk/manufacturing/first-rapid-covid-19-tests-21644413
Honestly, pre AGM announcments are not the norm! IMO its all positive updates coming through. If they did not give any news they are damned, when they give news updates they are damned, what do you want?
Brutal again 😢
...
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.